HIGHLIGHTS
- who: Ageratina adenophora and collaborators from the Central University of Technology, South Technology (CSIR), India have published the research: Ageratina adenophora (Spreng.) King & H. Rob. Standardized leaf extract as an antidiabetic agent for type 2 diabetes: An and in vivo evaluation, in the Journal: (JOURNAL)
- what: This study has been conducted to evaluate the capacity of Ageratina adenophora hydroalcoholic extract administered orally, for antihyperglycemic and antihyperlipidemic activities in normal, oral Frontiers in Pharmacology frontiersin.org 10.3389/fphar.2023.1178904 rats, there is an extensive breakdown of proteins to provide amino_acids for gluconeogenesis during insulin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.